| Novartis Pharma Schweiz AG - Sandostatin 0,1 mg/mL, Injektionslösung | | 49137 | | 02 | | Sandostatin 0,1 mg/mL | | Injektionslösung | | H01CB02 | | Octreotide | | 15.08.1988 | | |
| | Composition | | octreotidum 0.1 mg ut octreotidi acetas, mannitolum, acidum lacticum, natrii hydrogenocarbonas q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Octreotide | 0.1 mg |
| | BAG: Active Agent | Dose |
|---|
| Octreotide | 0.1 mg |
| | | | Inactive agents |
|---|
| Lactic Acid | | Mannitol | | Sodium Hydrogen Carbonate |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 044 | 5 1 ampoule(s) à 1 ml | 41.38 | 61.15 | A | SL | No |
|
|
